Post by
Goldnboy1 on Aug 02, 2023 11:22pm
Comparing to $TRIL
When $TRIL did their first big fundraising it was very similar to this. However for $100m Vs. $15m.
The same 15% over-allotment 30 day window was provided.
The stock ran to $10+ before Pfizer's involvement as shareholder was announced.
This $15m will not put the buyer over 10%. So there will likely be no disclosure.
I emailed the company first thing in the morning Monday. I offered a $250k-$500k order. My email didn't even get answered now three days later.
I believe the bought and USD nature of this raise means it is a major taking it all.
$TRIL did $100m but they were nearly broke. With Cash in hand, the full over allotment and the warrants cashing $ONC will have about $65M.
If the PanCan trial is a half off trial the numbers make perfect sense.
Hopefully Friday when it closes the stock absolutely rockets now that someone massive is priced in and ready to get greedy on market.
I don't think we will get a name on close, but you never know.
This weeks price dip will look like a steal a month from now. Management conference call planned this month. Have to think some big statements will come on that call to kick us into high gear!
Comment by
Lesalpes29 on Aug 03, 2023 8:02am
Good post. Selling pressure this week is normal. Nobody knows what or who is behind the financing. More details in the coming weeks and I still think positive news will follow. Thank you to the longs who are tacking time to analyse the actual situatuation. GL
Comment by
Buckhenry on Aug 03, 2023 12:04pm
I think they should focus on a blood clotting drug to help keep their stock from slowly bleeding to death.